Phase 12 · Quality

Outcomes measurement that actually means something.

Accreditation requires it. Payers increasingly ask for it. Investors and acquirers want it. And done right, outcomes data is the strongest evidence you can produce to a payer that your program deserves a better contract.

Phase 12 · Outcomes measurement

What "outcomes" means in behavioral health

Unlike surgical or oncology outcomes, behavioral health outcomes don't reduce to a single binary endpoint. The accepted framework includes:

  • Symptom reduction — measured by validated assessment instruments (PHQ-9 for depression, GAD-7 for anxiety, PCL-5 for PTSD, AUDIT for alcohol use, DAST-10 for drug use, etc.) administered at admission, throughout treatment, and at discharge
  • Functioning — work, school, relationships, housing stability. Tracked through structured intake and discharge questions plus follow-up survey
  • Substance use — UA results during treatment, self-reported use at discharge and follow-up
  • Engagement and retention — completion rates, length of stay, attendance at scheduled sessions
  • Post-discharge outcomes — 30/60/90-day follow-up survey for retention in recovery, return to work, emergency room visits, re-admission
  • Client satisfaction — Net Promoter Score or equivalent, satisfaction with specific aspects of programming

Validated instruments to use

Surveyors and payers prefer validated instruments over proprietary ones. The most widely accepted in behavioral health:

  • PHQ-9 — depression severity. Nine-item self-report. Widely used; well-validated.
  • GAD-7 — generalized anxiety severity. Seven items. Companion to PHQ-9.
  • PCL-5 — PTSD symptoms (DSM-5 criteria). Twenty items. Standard in trauma-focused programs.
  • AUDIT / AUDIT-C — alcohol use disorder screening. Ten items (AUDIT) or three (AUDIT-C).
  • DAST-10 — drug use screening. Ten items.
  • BAM (Brief Addiction Monitor) — multi-domain addiction outcome tracking. Used heavily in SAMHSA and VA contexts.
  • WHODAS 2.0 — functioning across six life domains.
  • Columbia Suicide Severity Rating Scale (C-SSRS) — suicide risk assessment. Required by most state rules and accreditors for SUD and behavioral health programs.
  • OQ-45 — Outcome Questionnaire. General psychological distress. Common in clinical-practice outcomes monitoring.

Measurement cadence

The standard pattern:

  • At admission — full assessment battery, baseline measure for every relevant instrument
  • Weekly or biweekly during treatment — shortened symptom measures (PHQ-9, GAD-7) to track in-treatment response. Many programs use these to inform treatment plan updates.
  • At discharge — full battery again. Discharge vs admission scores are the primary in-program outcome data.
  • 30-day follow-up — abbreviated survey, typically by phone or text. Highest response rate of any follow-up window.
  • 90-day follow-up — more focused survey covering recovery status, employment, housing, ER and re-admission events.
  • 6-month / 12-month follow-up — useful for payer and acquirer storytelling, harder to maintain response rates without dedicated alumni coordinator

What payers want to see

Commercial payers increasingly request outcomes data during re-contracting or rate negotiation. The data they value:

  • Admission vs discharge symptom scores (showing improvement)
  • Length of stay relative to ASAM/LOCUS criteria — too short suggests undertreatment; too long suggests unnecessary utilization
  • 30-day re-admission rate to any behavioral health level of care
  • 30-day post-discharge follow-up engagement rate
  • Completion rate by level of care
  • Outcomes parity across demographics (some payers now require this)

What accreditation surveyors look for

Both CARF and Joint Commission want to see an outcomes program that:

  • Collects data systematically — not ad hoc
  • Reports results to clinical leadership regularly (quarterly at minimum)
  • Triggers action — when outcomes data flags a problem, the QI committee actually does something about it
  • Is documented in the policy and procedure manual
  • Includes client feedback (satisfaction, grievance trends)

The single most common deficiency on this dimension is data being collected but never analyzed or acted on. The fix is a standing QI committee meeting with documented agenda, attendance, and action items.

The reporting program

A typical behavioral health outcomes reporting program produces:

  • Monthly dashboard — admissions, completions, length of stay, re-admissions, key clinical metrics
  • Quarterly QI report — deeper analysis, trended data, action items
  • Annual outcomes report — used externally with payers, referral sources, investors, and accreditation surveyors
  • Ad-hoc payer reports — produced on demand when a payer requests outcomes data during contract negotiation

Most of this should be automated out of the EMR. Manual outcomes-data extraction is a sign that the EMR isn't integrated with the assessment workflow — which is solvable. Navix builds outcomes tracking into the chart, not into a separate system.

Outcomes measurement is a clinical decision as much as a quality one. The instruments you choose, the cadence, and the interpretation framework should be set by your clinical leadership and validated by your medical director. Navix Launch contracts with outcomes-program designers who can build the QI program against your specific clinical model.

Ready to skip the guesswork? Let Navix run it.

Navix Launch is our end-to-end service for new and growing treatment centers. We lead the project; our contracted consultant network across the US covers licensing, accreditation, payer contracting, staffing, and clinical setup. Our head of compliance owns the project plan.